View All Documents & Correspondence
Succinic Acid And Derivatives For The Treatment Of Haemotological Disorders
Abstract: The present invention relates to succinic acid and its derivative(s) of Formula (I), their pharmaceutically acceptable salts, polymorphs, solvates, hydrates, co-crystals, isomers and solvates thereof as an active pharmaceutical ingredient for the treatment of haematological disorder(s). The present invention further relates to compounds of Formula (I), for the treatment of disorders selected from dengue, idiopathic thrombocytopenic purpura (ITP), anaemia and chemotherapy induced myelosuppression. The present invention also relates to use of succinic acid for the treatment of haematological disorder(s), wherein succinic acid is extracted from Papaya leaves. The present invention also provides pharmaceutical compositions comprising succinic acid and its derivative(s) of Formula I and methods of treating haematological disorder(s).
Notices, Deadlines & Correspondence
Patent Information
Applicants
ENZENE BIOSCIENCES LIMITED
Inventors
1. GADGIL, Himanshu
2. BANERJEE, Abir
3. CHAKRABORTY, Arindam
4. ADENWALA, Mazin
Specification
Documents
Application Documents
| # | Name | Date |
|---|---|---|
| 1 | 202147001979-STATEMENT OF UNDERTAKING (FORM 3) [15-01-2021(online)].pdf | 2021-01-15 |
| 2 | 202147001979-FORM 1 [15-01-2021(online)].pdf | 2021-01-15 |
| 3 | 202147001979-DRAWINGS [15-01-2021(online)].pdf | 2021-01-15 |
| 4 | 202147001979-DECLARATION OF INVENTORSHIP (FORM 5) [15-01-2021(online)].pdf | 2021-01-15 |
| 5 | 202147001979-COMPLETE SPECIFICATION [15-01-2021(online)].pdf | 2021-01-15 |
| 6 | 202147001979-Proof of Right [11-02-2021(online)].pdf | 2021-02-11 |
| 7 | 202147001979-FORM-26 [11-02-2021(online)].pdf | 2021-02-11 |
| 8 | 202147001979-FORM 3 [28-06-2021(online)].pdf | 2021-06-28 |
| 9 | 202147001979.pdf | 2021-10-18 |
| 10 | 202147001979-FORM 18 [13-06-2022(online)].pdf | 2022-06-13 |
| 11 | 202147001979-FER.pdf | 2022-08-02 |
| 12 | 202147001979-OTHERS [02-02-2023(online)].pdf | 2023-02-02 |
| 13 | 202147001979-Information under section 8(2) [02-02-2023(online)].pdf | 2023-02-02 |
| 14 | 202147001979-FORM 3 [02-02-2023(online)].pdf | 2023-02-02 |
| 15 | 202147001979-FER_SER_REPLY [02-02-2023(online)].pdf | 2023-02-02 |
| 16 | 202147001979-DRAWING [02-02-2023(online)].pdf | 2023-02-02 |
| 17 | 202147001979-CORRESPONDENCE [02-02-2023(online)].pdf | 2023-02-02 |
| 18 | 202147001979-COMPLETE SPECIFICATION [02-02-2023(online)].pdf | 2023-02-02 |
| 19 | 202147001979-CLAIMS [02-02-2023(online)].pdf | 2023-02-02 |
| 20 | 202147001979-ABSTRACT [02-02-2023(online)].pdf | 2023-02-02 |
| 21 | 202147001979-US(14)-HearingNotice-(HearingDate-11-04-2023).pdf | 2023-03-14 |
| 22 | 202147001979-Correspondence to notify the Controller [07-04-2023(online)].pdf | 2023-04-07 |
| 23 | 202147001979-FORM-26 [10-04-2023(online)].pdf | 2023-04-10 |
| 24 | 202147001979-PETITION UNDER RULE 138 [25-04-2023(online)].pdf | 2023-04-25 |
| 25 | 202147001979-Written submissions and relevant documents [26-05-2023(online)].pdf | 2023-05-26 |
| 26 | 202147001979-Annexure [26-05-2023(online)].pdf | 2023-05-26 |
Search Strategy
| 1 | search(4)E_26-07-2022.pdf |